Facebook
Twitter
LinkedIn
Forward
1st Annual Small Cell Lung Cancer Young Investigators' Forum - Call for Abstracts
The Small Cell Lung Cancer Young Investigators’ Forum (SCLC YIF) is a highly competitive research and professional development forum which strives to encourage, promote, and empower Young Investigators to forge collegial connections and acquire the necessary skills and relationships to increase their research productivity and catalyze their career trajectory in small cell lung cancer.
To complete your submission:
- Click on either the Register button above or the Take Course button to the right.
- If you already have a CE Concepts account, you will be asked to login. If not, you will need to create an account.
- Login to your account
- Click the Take Course button
- Click the arrow to the right of Abstract Submission in the Course Progress table:
- Click the Start button
- Complete the required fields
- To Upload an Abstract:
- Click Choose File
- Select the appropriate file from your desktop
- Click Open
- Click the Upload button – When the process is complete your document will appear as a link and a Remove button will appear
- To Upload an Abstract:
- Click Submit
Presented by Creative Educational Concepts, LLC in collaboration with LUNGevity.
 | 
|
Supported through an independent educational grant from Jazz Pharmaceuticals.
Target Audience
- North American-based Junior Faculty and Fellows (MDs, MD/PhDs, PhDs) involved in research related to Small Cell Lung Cancer (SCLC). We encourage thoracic oncologists, surgeons, radiation oncologists, pathologists, and related lab-based and translational researchers to submit!
- Junior Faculty (Instructors or Assistant Professors)
- Trainee (Must be enrolled in an ACGME-accredited fellowship program or PhD postdoctoral fellowship)
- Candidates must be based in North America and training must be completed at a North American-based institution.
- All work must be unpublished original research in an area related to SCLC. If your research has been disrupted due to COVID-19, we will also accept a Career Statement highlighting your goals and trajectory as related to this area, previously published information, journal club presentation, or other like projects representing professional development.
- Abstracts to be presented at future medical meetings are eligible for submission.
Learning Objectives
At the conclusion of this live activity, participants will be able to:
- Identify high-quality small cell lung cancer (SCLC) research study designs and methods, with an emphasis on subsequent lines of therapy, that may improve on current approaches to management of platinum-refractory disease.
- Review the current treatment landscape in SCLC, including the safety, efficacy, and pharmacology of established and emerging therapeutics, and discuss adaptive, patient-centric approaches to disease management in light of new data.
- Examine the impact of scholarly activity and clinical research on the continuing professional development of early-career physician scientists conducting active work in SCLC.
- Evaluate the strengths and weaknesses of SCLC research presented by Young Investigator peers.
- Improve public speaking and presentation skills to effectively communicate research findings to the larger scientific community.
- Recognize the crucial need for community-building among Young Investigators, especially those practicing in oncology, and analyze the mechanisms by which networking and collegiality enhance productivity and catalyze career trajectory in SCLC.
- Explore “what it takes” to become a successful SCLC researcher by discussing key career challenges, such as grant writing, research funding, networking, and academic appointments, among others, with leading KOLs and peers.
Additional Information
| Attachment | Size |
|---|---|
 Call for Abstracts | 115.78 KB |
Abstract Policies and Procedures:
- Only one abstract submission per Young Investigator will be accepted.
- Abstracts must conform to the abstract preparation instructions. Those that do not may be rejected.
- Only original work completed by the Young Investigator will be accepted.
- All accepted abstracts will be published in an electronic program to be provided to all attendees. The publication of electronic handout materials will not preclude publication or presentation elsewhere.
Selection Process:
- Expert Faculty Judges will review and score all submissions.
- Authors of the abstracts selected for presentation at the Forum will be expected to present their research according to their status at the time the research was completed (i.e., if research was conducted during fellowship training, it will be presented in the Fellows category).
- All presentations will be podium format and will consist of an 8-minute formal presentation with PowerPoint slides and a 7-minute question-answer period (15 minutes total).
Awards:
An awards ceremony will be held at the completion of the meeting, at which time the award winners will be announced. Grant payments will be made directly to the affiliated institution of each winning Young Investigator after the live, in-person program date.
Finalists:
The finalists (authors of accepted abstracts) must attend the meeting in its entirety and will be provided with the following from the organizer CEC:
- One round-trip, non-refundable, economy-class airline ticket, if outside the New Orleans area.
- A modest ground transportation stipend, or mileage reimbursement, for transfers to and from the program hotel in New Orleans.
- 2 nights lodging (Tuesday and Wednesday).
- All group buffet meals (breakfast, lunch, and dinner) for the duration of the meeting.
Items that will not be covered include:
- Ground transportation to and from your home airport
- Meals en route
- Baggage fees
Please note: Expenses for accompanying travelers will not be provided. Guests are not permitted to attend any portion of the meeting, including buffet meals. All travel arrangements will be made through a travel coordinator with Creative Educational Concepts.
Instructions for Abstract Preparation and Submission:
Identification: Upon entering the abstract submission website, you will be required to submit the following information:
- Full name, degree(s), credential(s)
- Mailing address
- Daytime telephone and e-mail
- Current institution
- Previous institution (where research was conducted, if applicable)
- Submitting author and study type: (Junior Faculty or Trainee)
- Photo
- Twitter Handle (if available)
Format: Abstracts should be uploaded as a Microsoft Word document with your last name in the document name.
Abstracts should consist of a brief title (bolded) descriptive of the research. Include first and last names and degrees of the authors. Underline the presenting author’s name and list the name and location of the institution where research was completed. Do not identify authors or institutions in the body of the abstract. Sans serif font (such as Arial or Helvetica) is preferred. Do not use font sizes smaller than 10 point.
Abstract text must be 1,000 words or less. Please make sure all figures are high resolution (at least 300 dpi). No more than a total of 4 figures and/or tables per submission are permitted. Please limit figures to 1 graph or image each (i.e., no multiple-part figures). Legends should be included with the abstract text and not as part of the figures (not included in the 1,000-word limit); figures should be embedded in the abstract file and not included as separate attachments.
Organize the body of the abstract in the following manner:
a) Disclosure of relevant financial relationships (not included in word count)
b) A sentence stating the purpose of the study
c) A brief statement of methods
d) A summary of results
e) A statement of conclusions reached.
Notification:
Abstract Receipt: An automatic notice confirming abstract submission, "Thank you, your submission has been received," will be provided upon completion of the online submission process.
Abstract Acceptance: Notification of abstract acceptance or rejection will be provided via e-mail in early June
Questions can be directed to Ashley C. Lilly, MHA at lillya@ceconcepts.com.
Tentative Agenda:
| Day | Key Components/Activities: Day | Key Components/Activities: Evening |
|---|---|---|
Tuesday |
|
|
Wednesday |
|
|
Thursday |
|
Charles M. Rudin, MD, PhD (Activity Chair)
Memorial Sloan Kettering
New York, NY
Ticiana Leal, MD (Steering Committee)
Emory Winship Cancer Institute
Atlanta, GA
It is the policy of Creative Educational Concepts, LLC, (CEC) to ensure independence, balance, objectivity, and scientific rigor and integrity in all their CME/CE activities. Activity planners, faculty, peer reviewers, and CEC staff must disclose to the participants any relationships with ineligible entities whose products or devices may be mentioned in this CE activity, or with the commercial supporter of this CE activity. An ineligible entity is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. Financial relationships may include research grants, consultant fees, travel, advisory boards, consultancy, speakers’ bureaus, other benefits, or having a self-managed equity interest in a company.
CEC has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Planners/Faculty:
Charles M. Rudin, MD, PhD–disclosures to come
Ticiana Leal, MD–disclosures to come
Faculty:
Information to come
Peer Reviewer:
Information to come
CEC Staff/Planners:
Tina L. Trieu, PharmD–has no relevant financial relationships to disclose in relation to the content of this activity.
Ashley C. Lilly, MHA–has no relevant financial relationships to disclose in relation to the content of this activity.
Faculty of this CME/CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices. CEC, the faculty, and any commercial supporter of this activity do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.
In support of improving patient care, Creative Educational Concepts is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.